ClinicalTrials.Veeva

Menu

Causes of Death in Follicular Lymphoma: a Single Center Retrospective Analysis

Civil Hospices of Lyon logo

Civil Hospices of Lyon

Status

Completed

Conditions

This Study Describes the Different Causes of Death in 237 FL Patients

Study type

Observational

Funder types

Other

Identifiers

NCT02951871
69HCL16_0719

Details and patient eligibility

About

Background.Although the life expectancy of patients with FL has recently increased, notably since the introduction of rituximab in combination with chemotherapy, little is known regarding the precise causes of patients death. Patients and methods'. This study describes the different causes of death in FL patients among followed since 2000 at Lyon University Hospital, centre Léon Bérard and Mayo Clinic. The causes of death will be classified as related to lymphoma progression, treatment-related toxicity (including TRM and secondary myelodysplastic syndrome/acute myeloid leukemia), secondary neoplasias, or other.

Enrollment

237 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • FL patients
  • patients recorded as deceased

Exclusion criteria

-Other diagnosis than FL

Trial design

237 participants in 4 patient groups

LP: Lymphoma Progression
TRM: Treatment Related Mortality
NHM: Non hematologic malignancy
OC: Other Cause

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems